tm
Seeing Is Believing
tm
Seeing Is Believing
FDMT is currently covered by 7 analysts with an average price target of $29.6. This is a potential upside of $20.99 (243.79%) from yesterday's end of day stock price of $8.61.
4D Molecular Therapeutics 's activity chart (see below) currently has 67 price targets and 73 ratings on display. The stock rating distribution of FDMT is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 34.03% with an average time for these price targets to be met of 120.3 days.
Highest price target for FDMT is $36, Lowest price target is $10, average price target is $25.33.
Most recent stock forecast was given by MATTHEW CAUFIELD from HC WAINWRIGHT on 20-Mar-2026. First documented stock forecast 05-Jan-2021.
Currently out of the existing stock ratings of FDMT, 12 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Nov-2022
$36
$27.39 (318.12%)
1 days ago
(20-Mar-2026)
0/15 (0%)
$27.39 (318.12%)
Buy Since 05-Jul-2023
$26
$17.39 (201.97%)
$26
2 days ago
(19-Mar-2026)
3/9 (33.33%)
$17.02 (189.53%)
201
Buy Since 15-Apr-2024
$33
$24.39 (283.28%)
4 months 10 days ago
(11-Nov-2025)
0/2 (0%)
$22.2 (205.56%)
Buy Since 08-Jun-2023
$31
$22.39 (260.05%)
4 months 18 days ago
(03-Nov-2025)
1/2 (50%)
$19.78 (176.29%)
243
Buy Since 15-Nov-2022
7 months 9 days ago
(12-Aug-2025)
0/2 (0%)
$52.76 (186.83%)
What is FDMT (4D Molecular Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on FDMT (4D Molecular Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on FDMT (4D Molecular Therapeutics )?
Which analyst is the currently most bullish on FDMT (4D Molecular Therapeutics )?
Which analyst is the currently most reserved on FDMT (4D Molecular Therapeutics )?
